Entheon Biomedical Corp. (ENTBF)
OTCMKTS · Delayed Price · Currency is USD
0.0790
0.00 (0.00%)
Feb 11, 2026, 9:30 AM EST
Entheon Biomedical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
1.01M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | - | - | - |
| Nov 30, 2023 | 250.32K | 60.65K | 31.97% |
| Nov 30, 2022 | 189.68K | - | - |
| Nov 30, 2021 | - | - | - |
| Nov 30, 2020 | - | - | - |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Evofem Biosciences | 17.73M |
| SQZ Biotechnologies Company | 12.12M |
| Emmaus Life Sciences | 11.89M |
| EV Biologics | 9.47M |
| International Stem Cell | 9.39M |
| Lipella Pharmaceuticals | 389.78K |
| Halberd | 6.94K |
Entheon Biomedical News
- 24 days ago - Entheon Announces Execution of Business Combination Agreement with Nutravisor - Newsfile Corp
- 7 weeks ago - Entheon Announces Letter of Intent with Nutravisor Inc. - Newsfile Corp
- 11 months ago - Entheon Announces Change of Directors - Newsfile Corp
- 11 months ago - Entheon Issues Incentive Stock Options - Newsfile Corp
- 11 months ago - Entheon Announces Termination of Mentis AI Agreement - Newsfile Corp
- 1 year ago - Entheon Announces Agreement to Acquire Mentis AI - Newsfile Corp
- 3 years ago - Entheon Announces Closing of Previously Announced Sale of Certain DMT Clinical Assets - Newsfile Corp
- 4 years ago - Entheon Announces Sale of Certain DMT Clinical Assets and Filing of Provisional Novel Compound Patents - Newsfile Corp